timothy sykes logo
CoreWeave (CRWV) Stock Rebounds As Wall Street Backs AI Cloud Expansion Thumbnail

CoreWeave (CRWV) Stock Rebounds As Wall Street Backs AI Cloud Expansion

TIM SYKESUPDATED AUG. 3, 2026, 12:33 PM ET
Reviewed by Jack Kelloggand Fact-checked by Ellis Hobbs

CoreWeave Inc. stocks have been trading up by 16.75 percent amid strong investor enthusiasm for its expanding AI cloud infrastructure.

Key Takeaways

  • Truist upgraded CRWV to Buy after a 42% pullback, pointing to strong AI compute demand, CoreWeave’s specialized cloud edge, and a discount to other neocloud names.
  • Oppenheimer sees CoreWeave’s Q2 revenue near the high end of guidance, keeps an Outperform and a $150 target, and calls overbuild worries overstated amid demand roughly four times supply.
  • An $8.5B loan facility is funding CRWV’s aggressive AI cloud build-out, putting CoreWeave in the same financing league as mega-cap tech on infrastructure scale.
  • A new Leidos partnership moves CoreWeave’s AI-native cloud into secure U.S. defense and intelligence data centers via CoreWeave Federal, signaling a push into sticky government workloads.
  • New York’s one-year moratorium on hyperscale data centers injects regulatory risk but may redirect AI build-outs toward regions where CoreWeave and peers face more supportive rules.

Candlestick Chart

Live Update At 12:32:48 EDT: On Monday, August 03, 2026 CoreWeave Inc. stock [NASDAQ: CRWV] is trending up by 16.75%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

CRWV has been trading like a true momentum name. After sliding from the low $90s in mid‑July to a low near $60.55 on 2026/07/29, CoreWeave has ripped back to close around $83.75, a sharp rebound that confirms aggressive dip‑buying. Recent daily ranges for CRWV show wide swings, which matter for traders: anyone playing this name must respect volatility.

Intraday, CRWV has stair‑stepped from the low $70s in premarket toward the mid‑$80s, with orderly 5‑minute higher lows most of the session. That tells traders demand is showing up on every pullback, not just in random spikes. For short‑term trading, CRWV is acting like a strong uptrend day rather than a choppy range.

Fundamentally, CoreWeave is still in heavy build‑out mode. Q1 revenue of about $2.08B and gross margin near 69% show that the core AI cloud business throws off rich unit economics. But CRWV is not yet printing bottom‑line profits: the company reported a net loss of roughly $740M and a profit margin around -25%. Leverage is high, with total debt to equity above 7x and a current ratio near 0.3, signaling tight liquidity and an aggressive capital structure. For traders, that mix—fast revenue growth, strong gross margin, and negative earnings—screams “high‑beta growth story,” not a sleepy value play.

Why Traders Are Watching CRWV’s AI Cloud Story

CRWV sits right at the center of the AI infrastructure trade, and the latest news flow around CoreWeave is giving momentum traders fresh fuel. Truist’s upgrade of CoreWeave to Buy after a 42% share price pullback is a big tell. The firm is essentially saying the market overreacted, while structural demand for AI compute remains intact. For short‑term traders, that kind of endorsement after a washout often marks a key sentiment turn.

Oppenheimer backs that view. The firm expects CoreWeave’s Q2 revenue to land at the high end of guidance and keeps an Outperform with a $150 target on CRWV. More importantly, Oppenheimer is openly pushing back on “overbuild” fears, arguing AI compute demand is running at roughly four times current supply and GPU pricing is still rising. When two major firms line up on the same bullish side of the trade, many CRWV watchers take notice.

The balance sheet tells the same story in a louder voice. In March, CoreWeave locked down an $8.5B loan facility to expand its AI cloud platform. That is mega‑scale capital for a neocloud name and underscores how serious CoreWeave is about racing to add capacity. The flip side is execution risk: CRWV’s free cash flow was about -$4.7B recently, and capital expenditures ran close to $7.7B. This is a “spend now, monetize later” model.

Meanwhile, CoreWeave is widening its demand base. The Leidos collaboration pushes the CoreWeave Federal business into SCIF‑accredited data centers for secure U.S. defense and intelligence workloads. Those government contracts tend to be sticky and long term, which can smooth out the wild cycles traders see day to day in CRWV.

Regulation is becoming another trading catalyst. New York’s one‑year moratorium on new hyperscale data centers adds uncertainty, but it also reinforces the idea that AI infrastructure demand is strong enough to collide with local politics. Analysts expect CoreWeave, along with peer Nebius, to benefit as data center spending migrates toward more welcoming regions. For CRWV traders, that’s less about whether capacity gets built and more about where—and at what cost.

Conclusion

CRWV is shaping up as one of those high‑octane AI names where the story and the tape are finally lining up again. The stock’s rebound from the low $60s back into the $80s comes as Truist upgrades CoreWeave to Buy and Oppenheimer reiterates an Outperform rating with a $150 target. Both firms are leaning into the same theme: CoreWeave’s specialized AI cloud is still operating in a market where demand massively outstrips supply.

Under the hood, the numbers show what CoreWeave is really doing with CRWV shareholders’ capital—pouring it into data centers, GPUs, and networking at a blistering pace. The $8.5B loan facility, negative free cash flow, and high leverage tell traders this is not a conservative balance sheet. It is a leveraged bet that CoreWeave’s AI‑native cloud, plus deals like the Leidos defense partnership and growing workloads through partners such as Core Scientific, will pay off over time.

For active traders, that kind of setup demands discipline. The price swings in CRWV are big, and the fundamental story is powerful but still unproven at the earnings line. As Tim Sykes loves to remind his community, “Cut losses quickly, don’t fall in love with any stock.” As millionaire penny stock trader and teacher Tim Sykes, says, “Be patient, don’t force trades, and let the perfect setups come to you.”. With CoreWeave, that means respecting the trend, watching key levels on the chart, and treating every trade as a learning opportunity in a fast‑moving AI infrastructure name. This article is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:


How much has this post helped you?



Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”